Has CareDx (CDNA) Outpaced Other Medical Stocks This Year?

Zacks12-03

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is CareDx (CDNA) one of those stocks right now? By taking a look ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2488494034?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/xMhOxlfdhVA7Ts3pP3IHyA--~B/aD02MzM7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b369e357aa3d42cc28ac674490d4ae83","is_english":true,"pubTime":"2024-12-03 22:40","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2488494034","market":"us","top_or_hot":-1,"title":"Has CareDx (CDNA) Outpaced Other Medical Stocks This Year?","media":"Zacks","content":"<div>\n<p>The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is CareDx (CDNA) one of those stocks right now? By taking a look ...</p>\n\n<a href=\"https://finance.yahoo.com/news/caredx-cdna-outpaced-other-medical-144012214.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Has CareDx (CDNA) Outpaced Other Medical Stocks This Year?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHas CareDx (CDNA) Outpaced Other Medical Stocks This Year?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-03 22:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/caredx-cdna-outpaced-other-medical-144012214.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is CareDx (CDNA) one of those stocks right now? By taking a look ...</p>\n\n<a href=\"https://finance.yahoo.com/news/caredx-cdna-outpaced-other-medical-144012214.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CDNA","symbol_name":"CareDx","start_time":0,"source_url":"https://finance.yahoo.com/news/caredx-cdna-outpaced-other-medical-144012214.html","article_id":"2488494034","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/xMhOxlfdhVA7Ts3pP3IHyA--~B/aD02MzM7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b369e357aa3d42cc28ac674490d4ae83"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2488494034","pubTimestamp":1733236812,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is CareDx  one of those stocks right now?By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.CareDx is a member of the Medical sector. This group includes 1025 individual stocks and currently holds a Zacks Sector Rank of #3. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.According to our latest data, CDNA has moved about 113.7% on a year-to-date basis. Meanwhile, the Medical sector has returned an average of 2.1% on a year-to-date basis. This means that CareDx is performing better than its sector in terms of year-to-date returns.Another stock in the Medical sector, Clover Health Investments, Corp. , has outperformed the sector so far this year. The stock's ","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"CDNA":"CareDx","BK4547":"WSB热门概念","CLOV":"Clover Health Corp","BK4139":"生物科技","BK4154":"管理型保健护理"},"translate_title":"CareDx(CDNA)今年的表现是否超过了其他医疗股？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CDNA":1,"CLOV":1},"content_text":"The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is CareDx (CDNA) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.\nCareDx is a member of the Medical sector. This group includes 1025 individual stocks and currently holds a Zacks Sector Rank of #3. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.\nThe Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. CareDx is currently sporting a Zacks Rank of #2 (Buy).\nOver the past 90 days, the Zacks Consensus Estimate for CDNA's full-year earnings has moved 16.7% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.\nAccording to our latest data, CDNA has moved about 113.7% on a year-to-date basis. Meanwhile, the Medical sector has returned an average of 2.1% on a year-to-date basis. This means that CareDx is performing better than its sector in terms of year-to-date returns.\nAnother stock in the Medical sector, Clover Health Investments, Corp. (CLOV), has outperformed the sector so far this year. The stock's year-to-date return is 260.3%.\nFor Clover Health Investments, Corp. the consensus EPS estimate for the current year has increased 7.7% over the past three months. The stock currently has a Zacks Rank #2 (Buy).\nBreaking things down more, CareDx is a member of the Medical Services industry, which includes 59 individual companies and currently sits at #138 in the Zacks Industry Rank. On average, stocks in this group have lost 5.4% this year, meaning that CDNA is performing better in terms of year-to-date returns.\nIn contrast, Clover Health Investments, Corp. falls under the Medical Info Systems industry. Currently, this industry has 42 stocks and is ranked #34. Since the beginning of the year, the industry has moved -3.7%.\nInvestors interested in the Medical sector may want to keep a close eye on CareDx and Clover Health Investments, Corp. as they attempt to continue their solid performance.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nCareDx, Inc. (CDNA) : Free Stock Analysis Report\nClover Health Investments, Corp. (CLOV) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2488494034"}